Heart failure & cardiomyopathies

Polypharmacy on first admission to hospital for people with heart failure: baseline findings from the PULSE cohort

Eur Heart J Qual Care Clin OutcomesPublished Retrospective cohort study

Authors' conclusion

Polypharmacy is common on first admission to hospital for people with heart failure. More medications at admission are associated with increasing age, co-morbidity, and frailty. People with polypharmacy are more likely to have a heart failure with preserved ejection fraction diagnosis, have worse symptoms and a longer hospital stay.

Study context

Population
Patients on first hospital admission for HF (PULSE cohort)
Participants
660 patients
Outcome
Polypharmacy prevalence
Follow-up
First HF admission
Methodological detailssingle-centre, longitudinal, observational
  • Single-centre
  • Longitudinal
  • Observational

Main finding

As reported in the abstract

Polypharmacy prevalence on admission
87.3%
Polypharmacy prevalence at discharge
95.1%
Admission vs discharge
P < 0.001
Median number of medications on admission (25th-75th centile 7-12)
9
Median number of medications on discharge (25th-75th centile 8-13)
10

Observational data: associations, not effects.

Further findings

Mean medication complexity index score · admission vs discharge

Admission (±SD 14.9)
28.5
Discharge (±14.1)
31.8
Increase admission to discharge
P < 0.001

Factors associated with more medications on admission

Increasing age
P < 0.001
Higher Charlson Co-morbidity Index
P < 0.001
More co-morbidities
P < 0.001
Higher Clinical Frailty Scale
P < 0.001
Longer length of stay
P = 0.03
Worse NYHA class
P = 0.04
HFpEF vs HFrEF
P = 0.002

Medication profile

CV medications share of medications
50%
Prescribing of HF medications reduced with increased polypharmacy

Original publication

Polypharmacy on first admission to hospital for people with heart failure: baseline findings from the PULSE cohort. Eur Heart J Qual Care Clin Outcomes. Published 16 May 2025. doi:10.1093/ehjqcco/qcaf032

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.